Travel Health Evidence

Praktiskt

Atferð í útlondum við cøliaki ella matallergi

Ein málbariera ger eina stýrda støðu til ein vøtt. Loysningin er mest logistisk, og tað er vert at gera áðrenn tú fer.

Uppdatert 2 min lesing 22 tilvísingar Dokumentasjonsstyrkur 3/5

Hvat EU-reglur geva tær

Teir fjórtán høvuðsallergenir — við ídnaðarmati, sum inniheldur gluten — skulu verða lýstir í EU, í pakkaðum mati og í matþjónustu. Reglurnar eru nóg mikið eins, at ein cøliaki ferðandi, sum flytur millum limalond, stendur frammi fyri sama merkingarskipan, sum er ein stórur og undirmettur fyrimunur.

Hvat er ymist er handfaring, hvussu matþjónustan avdúkar (munnliga, á eini matseðli, í eini mappa), og mentanarlig kunnleiki við støðuni. Nokkir lond hava høga almennan kunnleika um cøliaki; onnur viðgera tað sum ein fyrimun.

Tað praktiska systemið

  1. Fá eitt týðingarkort á lokalum máli, har støðan er lýst lækniliga, nevndur hvat skal undvikast, og nevndur deildar frityrur og ytir. Ein kort fer til køkin; ein talað setning fer ikki.
  2. Lær at lesa innihaldslistan, ikki málið. Allergenar eru framhevaðir typografiskt í EU, so tú kanst finna teir uttan at lesa restina.
  3. Bóka íbúð við køli og ketli. Tað broytir ein torføran túr til ein vanligan.
  4. Hava tryggan mat til ferðadagar. Flúgvar, støð og longar ferðir eru har fólk verða fangin.
  5. Finn lokal cøliaki ella allergifelag. Flestu evropeisku lond hava eitt, fleiri publisera staðalistar.
  6. Taka nóg mikið av medisin — við ídnaðarmati sjálv-innsprøttum har tað er relevant — og hava eitt uppskriftarbref.

Trygging og dokumentatión

Sjekka at ferðatryggingin fevnir um tínar støður, og hava dokumentatión av hvørjari medisin í upprunaligum pakka við einum uppskriftarbrefi. Innan EU, fevnir Evropeiska Heilsutryggingarkortið um neyðuga statsliga veittari behandling, sum ikki er tað sama sum ferðatrygging og ikki kemur í staðin fyri tað.

Vanligar spurningar

Eru týðingarkort veruliga gagnlig?
Ja, meira enn at tosa. Ein kort kann verða givin til køkin, har avgerðirnar verða tiknar.
Hvilke evropeisku lond eru lættast við cøliaki?
Kunnleiki er ymiskari enn reglugerðin. Nasjonalar cøliaki felag eru besti núverandi keldan heldur enn nakra generalisering.
Kann eg taka mína medisin yvir landamørk?
Vanliga ja í upprunaligum pakka við einum uppskriftarbrefi. Sjekka stýrda evni serliga.
Hvat um eg fái gluten í útlondum?
Stýra symptomum og vøtt. Einki er til fyri eina útseting — sí okkara cøliaki heimasíðu.

Viðmerkingar

Hver einasta tilvísing niðanfyri bendir til upprunaliga peer-reviewed skjalið á PubMed ella gjøgnum DOI. Einki her er ein staðfesting fyri læknaligt ráð.

  1. Selected laboratory-based biomarkers for assessing vitamin A deficiency in at-risk individuals Gannon BM, Huey SL, Mehta NH, et al. · The Cochrane database of systematic reviews · 2025 · Meta-analysis DOIPubMed 40433851Full text
  2. Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis Raffetin A, Henningsson AJ, Ornstein K, et al. · Infection · 2025 · Meta-analysis DOIPubMed 40246800
  3. Non-pharmacological interventions designed to support carriers of multi-drug-resistant organisms (MDROs): a systematic literature review Gaube S, Pan M, Rath A, et al. · The Journal of hospital infection · 2025 · Systematic review DOIPubMed 40816599
  4. Risk of anaphylaxis on commercial flights Turner PJ · Current opinion in allergy and clinical immunology · 2025 · Systematic review DOIPubMed 40643054Full text
  5. How Common Are Allergic Reactions During Commercial Flights? A Systematic Review and Meta-Analysis Turner PJ, Mamula J, Laktabi J, et al. · The journal of allergy and clinical immunology. In practice · 2023 · Meta-analysis DOIPubMed 37507067
  6. Skin care interventions in infants for preventing eczema and food allergy Kelleher MM, Cro S, Cornelius V, et al. · The Cochrane database of systematic reviews · 2021 · Meta-analysis DOIPubMed 33545739Full text
  7. The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations Abraham A, Bustos JA, Carabin H, et al. · PLoS neglected tropical diseases · 2021 · Meta-analysis DOIPubMed 33788843Full text
  8. Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact Mouchtouri VA, Christoforidou EP, An der Heiden M, et al. · International journal of environmental research and public health · 2019 · Systematic review DOIPubMed 31766548Full text
  9. Frequency, severity and causes of unexpected allergic reactions to food: a systematic literature review Versluis A, Knulst AC, Kruizinga AG, et al. · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2015 · Systematic review DOIPubMed 24766413
  10. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community Muraro A, Agache I, Clark A, et al. · Allergy · 2014 · Clinical guideline DOIPubMed 24905609
  11. Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections Domingues AR, Pires SM, Halasa T, et al. · Epidemiology and infection · 2012 · Meta-analysis DOIPubMed 22214729
  12. Effects of pregnancy and lactation prebiotics supplementation on infant allergic disease: A randomized controlled trial Palmer DJ, Cuthbert AR, Sullivan TR, et al. · The Journal of allergy and clinical immunology · 2025 · Randomised controlled trial DOIPubMed 39173718
  13. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial Kliewer KL, Gonsalves N, Dellon ES, et al. · The lancet. Gastroenterology & hepatology · 2023 · Randomised controlled trial DOIPubMed 36863390Full text
  14. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial Jackson DJ, Bacharier LB, Gergen PJ, et al. · Lancet (London, England) · 2022 · Randomised controlled trial DOIPubMed 35964610Full text
  15. Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper Pascal M, Chauhan J, Knol E, et al. · Allergy · 2025 · Review DOIPubMed 40503572Full text
  16. The epithelial barrier theory and its associated diseases Sun N, Ogulur I, Mitamura Y, et al. · Allergy · 2024 · Review DOIPubMed 39370939Full text
  17. Travel Medicine Leung DT, LaRocque RC, Ryan ET · Annals of internal medicine · 2018 · Review DOIPubMed 29297035
  18. The restaurant syndromes Settipane GA · New England and regional allergy proceedings · 1987 · Review DOIPubMed 3302666
  19. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092927Full text
  20. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092926Full text
  21. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 The Lancet. Neurology · 2024 · Journal article DOIPubMed 39304265Full text
  22. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019 Shin YH, Hwang J, Kwon R, et al. · Allergy · 2023 · Journal article DOIPubMed 37431853Full text

Henda síða varð sjálvvirkandi týdd úr enskt. Tilvísingarnar og tølini eru óbroytt. Les upprunaliga enska útgávuna um nakað lesist undarliga. Les upprunaliga enska útgávuna